Trial of Ascorbic Acid (AA) + Nanoparticle Paclitaxel Protein Bound + Cisplatin + Gemcitabine (AA NABPLAGEM)

NCT03410030 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

27

Enrollment

OTHER

Sponsor class

Conditions

Pancreatic Cancer
Pancreas Cancer
Pancreatic Adenocarcinoma Resectable
Pancreatic Ductal Adenocarcinoma
Pancreas Metastases

Interventions

DRUG: Ascorbic Acid
DRUG: Paclitaxel protein-bound
DRUG: Cisplatin
DRUG: Gemcitabine

Sponsor

HonorHealth Research Institute

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]